Type | Name | Gene Symbol | Clinical Significance | Chromosome | Start | Stop | Reference Allele | Alternate Allele | Review Status | Other IDs |
---|---|---|---|---|---|---|---|---|---|---|
(GRCh37) | ||||||||||
Duplication | NM_000059.3(BRCA2):c.4228_4229insA (p.Thr1410Asnfs) | BRCA2 | Pathogenic | 13 | 32912718 | 32912719 | T | TA | reviewed by expert panel | ClinGen:CA10586066 |
Duplication | NM_000059.3(BRCA2):c.4722dup (p.Asp1575fs) | BRCA2 | Pathogenic | 13 | 32913211 | 32913212 | T | TA | reviewed by expert panel | ClinGen:CA10586069 |
Deletion | NM_000059.4(BRCA2):c.4731del (p.Glu1577fs) | BRCA2 | Pathogenic | 13 | 32913222 | 32913222 | GA | G | reviewed by expert panel | ClinGen:CA10586070 |
Deletion | NM_000059.4(BRCA2):c.5241del (p.Asn1747fs) | BRCA2 | Pathogenic | 13 | 32913733 | 32913733 | AC | A | reviewed by expert panel | ClinGen:CA10586072 |
single nucleotide variant | NM_000059.4(BRCA2):c.5293A>T (p.Lys1765Ter) | BRCA2 | Pathogenic | 13 | 32913785 | 32913785 | A | T | reviewed by expert panel | ClinGen:CA10586073 |
Deletion | NM_000059.4(BRCA2):c.5590_5593del (p.Asp1864fs) | BRCA2 | Pathogenic | 13 | 32914081 | 32914084 | AAGAC | A | reviewed by expert panel | ClinGen:CA10586075 |
Duplication | NM_000059.4(BRCA2):c.7654dup (p.Ile2552fs) | BRCA2 | Pathogenic | 13 | 32931910 | 32931911 | T | TA | reviewed by expert panel | ClinGen:CA10586078 |
Deletion | NM_000059.3(BRCA2):c.8312del (p.Pro2771fs) | BRCA2 | Pathogenic | 13 | 32937648 | 32937648 | GC | G | reviewed by expert panel | ClinGen:CA10586084 |
single nucleotide variant | NM_000059.4(BRCA2):c.9285C>A (p.Asp3095Glu) | BRCA2 | Pathogenic/Likely pathogenic | 13 | 32968854 | 32968854 | C | A | criteria provided, multiple submitters, no conflicts | ClinGen:CA10586089 |
Deletion | NM_007294.4(BRCA1):c.1407_1408del (p.Ser470fs) | BRCA1 | Pathogenic | 17 | 41246140 | 41246141 | CTT | C | reviewed by expert panel | ClinGen:CA10586093 |